# The Effects of Pentoxifylline on PAI-1 in an Obese Population

> **NCT00770328** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 37 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00770328
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770328, "The Effects of Pentoxifylline on PAI-1 in an Obese Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00770328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*